Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 5 | 2020 | 403 | 0.970 |
Why?
|
| Prostatic Neoplasms | 5 | 2020 | 1092 | 0.700 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 8 | 0.650 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 31 | 0.640 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 291 | 0.620 |
Why?
|
| Androgens | 1 | 2020 | 106 | 0.610 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 968 | 0.600 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 55 | 0.480 |
Why?
|
| Cytokines | 1 | 2016 | 678 | 0.370 |
Why?
|
| Inflammation | 1 | 2016 | 758 | 0.330 |
Why?
|
| HIV-1 | 3 | 2022 | 755 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 526 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 1723 | 0.220 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 2676 | 0.200 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2021 | 17 | 0.180 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 55 | 0.180 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 144 | 0.170 |
Why?
|
| Quinolines | 1 | 2020 | 78 | 0.160 |
Why?
|
| Transferrin | 2 | 2008 | 38 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 2 | 2016 | 508 | 0.130 |
Why?
|
| Interleukin-5 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Chemokine CXCL5 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Azacitidine | 1 | 2016 | 21 | 0.130 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 33 | 0.120 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 80 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2016 | 55 | 0.120 |
Why?
|
| Humans | 12 | 2022 | 43102 | 0.110 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2012 | 27 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 455 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 590 | 0.100 |
Why?
|
| CpG Islands | 1 | 2012 | 109 | 0.090 |
Why?
|
| Male | 5 | 2020 | 23409 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 102 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 100 | 0.090 |
Why?
|
| Protein Phosphatase 1 | 2 | 2022 | 70 | 0.090 |
Why?
|
| Genes | 1 | 2010 | 56 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2012 | 561 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 223 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 150 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2022 | 986 | 0.070 |
Why?
|
| Prostate | 1 | 2010 | 155 | 0.070 |
Why?
|
| Infrared Rays | 1 | 2008 | 21 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 26 | 0.070 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 29 | 0.070 |
Why?
|
| HIV Infections | 1 | 2021 | 2586 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 81 | 0.060 |
Why?
|
| Aged | 3 | 2019 | 8214 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 224 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 182 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2010 | 735 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 1596 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.050 |
Why?
|
| Middle Aged | 3 | 2019 | 12222 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 168 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 587 | 0.050 |
Why?
|
| Haplotypes | 1 | 2004 | 197 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 16 | 0.040 |
Why?
|
| Mice | 4 | 2022 | 6644 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2021 | 37 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 216 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 62 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 113 | 0.040 |
Why?
|
| Adult | 2 | 2019 | 13872 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 247 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 321 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2022 | 592 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 318 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 701 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Proteins | 1 | 2020 | 382 | 0.030 |
Why?
|
| Fluorescence | 2 | 2008 | 118 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 861 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1067 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1285 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 16992 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2853 | 0.020 |
Why?
|
| Female | 1 | 2012 | 24698 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2010 | 10 | 0.020 |
Why?
|
| Osteonectin | 1 | 2010 | 10 | 0.020 |
Why?
|
| Health | 1 | 2010 | 30 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5080 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 515 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6081 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 15 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 25 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 129 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 71 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 49 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2007 | 23 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 118 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2007 | 34 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 114 | 0.020 |
Why?
|
| Magnetics | 1 | 2007 | 43 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2010 | 434 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 408 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 132 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 347 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 107 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 495 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 983 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3994 | 0.010 |
Why?
|